The augmentation of new technologies has benefitted healthy ageing and longevity tremendously, by enabling people to live healthier, more fulfilling lives at all ages. More and more technological innovations are being deployed to keep people physically active and support independent living through smart home technology, early detection of diseases etc.
According to a report in World Economic forum, Life expectancy has increased to 70 years or more in many countries. In 2020, for the first time in history, individuals aged 60 or older outnumbered children under the age of five. This huge feat has been accomplished through better nutrition, better healthcare and of late, by employing technological innovations, big data and artificial intelligence to improve life expectancy and meet the demands of an ageing population.
Although aging isn’t a treatable disorder or condition, tech companies and researchers dedicated to longevity are looking at bodily processes at the cellular level to see how aging progresses and formulate right drugs, treatments and vitamins that might slow these processes down.
Companies such as Juvenescence AI are bringing together drug development and artificial intelligence fully focused on ageing and age-related diseases. In Its joint venture with deep learning drug discovery company Insilico Medicine, they are working on developing both pharmaceutical and nutraceutical products that target ageing cells.
Another startup, Cellularity, is working on new approaches for the treatment of Cancer, Infectious Diseases and Degenerative Diseases through continuous, innovative application of new discoveries in cellular medicine.
As a vital part of regenerative medicine, 3D bioprinting of tissues and organs present a novel way to restore lost structures or functions. For example, Prellis Biologics is building human tissues for drug development, and ultimately planning to develop human organs for transplantation.
LyGenesis Inc., is a biotechnology company focused on organ regeneration. Their technology uses lymph nodes as bioreactors to regrow functioning organs within a patient's own body. This financing will enable LyGenesis's lead program in liver regeneration to transition into clinical development, beginning with a Phase 2a clinical trial for patients with end stage liver disease by 2021.
Dietary supplements such as NAD+ has been receiving a lot of attention recently. It is a naturally occurring key molecule known as a coenzyme which regulates healthy metabolism and other biological processes in the body. Elysium Health‘s daily supplement, Basis, seeks to elevate these NAD+ levels in the body in order to prolong one’s lifespan.
Another company, Longevica says it created a biotechnology platform for longevity after researching the life-span of laboratory mice. It now aims to produce medicines, dietary supplements and food products.
While not all of these ventures might help cure aging, we believe that the growing interest and investment in longevity technologies shows that we are on the right path to do so.
Credits : Akhil Handa